<DOC>
	<DOC>NCT01159561</DOC>
	<brief_summary>This study is designed to determine the safety and immunogenicity of WEE Vaccine Lot number 3-1-92.</brief_summary>
	<brief_title>Western Equine Encephalitis Vaccine</brief_title>
	<detailed_description>Study Objectives: Primary: To assess safety of the Western Equine Encephalitis (WEE) Vaccine, Inactivated, TSI-GSD 210, lot 3-1-92. Secondary: To evaluate immunogenicity of the Western Equine Encephalitis (WEE) Vaccine, Inactivated, TSI-GSD 210, lot 3-1-92.</detailed_description>
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalomyelitis, Equine</mesh_term>
	<mesh_term>Encephalomyelitis, Western Equine</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1855 years of age In good health as determined by pertinent medical history, brief physical exam, vital signs, and clinical safety laboratory evaluations Female: has a negative urine pregnancy test and is willing to use reliable form of contraception for the study duration Negative HIV antibody screen, seronegative for HBsAg and Hepatitis C antibody WEE, EEE, VEE, and CHIK PRNT80&lt;1:10 Ability to comprehend abnd a willingness to sign an informed consent, which includes the HIPAA and a separate HIV consent form Be willing to comply with all followup visits, testing, and AE reporting Participant in the USAMRIID SIP Receipt of any other vaccine or investigational; drug within 30 days prior to study entry Anticipates receipt of other vaccines for the duration of the study (influenza vaccination will be permitted but not within 28 days of WEE vaccination Acute of chronic medical conditions, medications, or dietary supplements that, in the PI's opinion, would impair the subject's ability to respond to vaccination Hypersensitivity to any vaccine Allergic to any vaccine component: Human serum albumin, Neomycin Receipt of or anticipates receipt of blood products during the study Female: Pregnant or breastfeeding Clinically significant abnormal laboratory tests (generally greater than or equl to 2 times the upper limit of normal as determined by the PI)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>